Cowlen M S, Hewitt W R, Schroeder F
Toxicol Appl Pharmacol. 1984 May;73(3):478-91. doi: 10.1016/0041-008x(84)90100-5.
Rats were treated with [14C]chloroform (14CHCl3) in corn oil (CO) or corn oil alone 18 hr following pretreatment with 2-hexanone (2-HX) in corn oil or corn oil alone. Livers were removed, homogenized 1,2, and 6 hr post-14CHCl3 administration, and glutathione (GSH) content, irreversible binding of 14CHCl3-derived radiolabel, and phospholipid composition were determined. The combination of 2-HX + CHCl3 reduced GSH content to 21% of control (CO + CO) 1 hr after CHCl3 administration. No significant rebound of GSH was observed 24 hr post-CHCl3 administration. In contrast, GSH was not altered by administration of CHCl3 to CO-pretreated rats. Although 14CHCl3-derived radiolabel was irreversibly bound to hepatic macromolecules of both CO- and 2-HX-pretreated rats, total irreversibly bound 14C was significantly enhanced in 2-HX-pretreated rats at all time points. The latter observation was consistent with the decrease in GSH of 2-HX-pretreated rats. Total 14C binding in 2-HX-pretreated rats reached a plateau 2 hr post-14CHCl3 administration and was distributed 52% in protein, 41% in lipid, and 7% in acid soluble fractions 6 hr post-14CHCl3 administration. 2-HX enhanced 14C binding to protein and lipid at each time point. Radiolabel was not detected in neutral lipids of control or 2-hexanone-treated animals, but was enhanced 33-fold in phospholipids of 2-hexanone-treated animals. Phospholipid fatty acid methyl ester derivatives did not contain 14C indicating the radiolabel was most likely associated with phospholipid polar head groups. Two dimensional thin layer chromatographic analysis of phospholipid from treated animals demonstrated that 87% of the total radiolabel was associated with a specific phospholipid (14C-PL) which had a 1:1 molar ratio of phosphate to 14C. The latter indicates that the 14C-PL was a monophospholipid derivative of 14CHCl3 reactive intermediate, generally thought to be phosgene. Concurrent decrease in phosphatidylethanolamine content from 23% of total phospholipid to 7%, accumulation of 14C-PL to 2.6% of total phospholipid, and increase in lysophosphatidylethanolamine from 1 to 7% of total phospholipid during 2-hexanone + 14CHCl3 treatment indicated that the amine moiety of phosphatidylethanolamine polar head groups was the probable target of phosgene-lipid interaction, and that a degradative pathway existed which removed the abnormal phospholipid from hepatic membranes. No phospholipid other than phosphatidylethanolamine was depleted. During models studies, 2% phosgene in toluene was reacted with liver phosphatidylethanolamine for 6 hr at 37 degrees C.(ABSTRACT TRUNCATED AT 400 WORDS)
在玉米油(CO)中用[14C]氯仿(14CHCl3)或仅用玉米油对大鼠进行处理,处理前18小时,在玉米油中或仅用玉米油对大鼠进行2 - 己酮(2 - HX)预处理。在给予14CHCl3后1、2和6小时取出肝脏,进行匀浆,并测定谷胱甘肽(GSH)含量、14CHCl3衍生放射性标记的不可逆结合以及磷脂组成。在给予氯仿后1小时,2 - HX + CHCl3组合使GSH含量降至对照组(CO + CO)的21%。在给予氯仿后24小时未观察到GSH的显著反弹。相比之下,对用CO预处理的大鼠给予氯仿后,GSH未发生改变。尽管14CHCl3衍生的放射性标记不可逆地结合到CO预处理和2 - HX预处理大鼠的肝脏大分子上,但在所有时间点,2 - HX预处理大鼠中总的不可逆结合14C显著增加。后一观察结果与2 - HX预处理大鼠中GSH的降低一致。在2 - HX预处理大鼠中,总的14C结合在给予14CHCl3后2小时达到平台期,在给予14CHCl3后6小时,52%分布在蛋白质中,41%分布在脂质中,7%分布在酸溶性部分。在每个时间点,2 - HX增强了14C与蛋白质和脂质的结合。在对照组或2 - 己酮处理动物的中性脂质中未检测到放射性标记,但在2 - 己酮处理动物的磷脂中增强了33倍。磷脂脂肪酸甲酯衍生物不含14C,表明放射性标记最可能与磷脂极性头部基团相关。对处理动物的磷脂进行二维薄层色谱分析表明,总放射性标记的87%与一种特定磷脂(14C - PL)相关,该磷脂的磷酸盐与14C的摩尔比为1:1。后者表明14C - PL是14CHCl3反应中间体的单磷脂衍生物,一般认为是光气。在2 - 己酮 + 14CHCl3处理期间,磷脂酰乙醇胺含量从总磷脂的23%降至7%,14C - PL积累至总磷脂的2.6%,溶血磷脂酰乙醇胺从总磷脂的1%增加至7%,这表明磷脂酰乙醇胺极性头部基团的胺部分可能是光气 - 脂质相互作用的靶点,并且存在一条降解途径,可从肝细胞膜中去除异常磷脂。除磷脂酰乙醇胺外,没有其他磷脂减少。在模型研究中,将甲苯中的2%光气与肝磷脂酰乙醇胺在37℃下反应6小时。(摘要截短至400字)